John M. Bennett, M.D.

See information for Patients. Viewing information for Researchers.

Contact

335 Avalon Drive
Rochester, NY 14618

Office: 585 275-4915

Fax: 585 442-0039

Current Appointments

Education
MD Medicine Boston University Sch Medicine 1959
BA Arts & Sciences Harvard University 1955
Post-Doctoral Training & Residency
Fellow in Hematology (Tufts), Boston City Hospital 1962 - 1963
Resident in Medicine, Beth Israel Hospital, Boston, Massachusetts 1960 - 1962
Intern, Massachusetts Memorial Hospital 1959 - 1960
Recent Journal Articles
Showing the 5 most recent journal articles. (502 available)
Cheson,B. D.; Greenberg,P. L.; Bennett,J. M.; Lowenberg,B.; Wijermans,P. W.; Nimer,S. D.; Pinto,A.; Beran,M.; de Witte,T. M.; Stone,R. M.; Mittelman,M.; Sanz,G. F.; Gore,S. D.; Schiffer,C. A.; Kantarjian,H.;. "Clinical application and proposal for modification of the international working group (IWG) response criteria in myelodysplasia". Blood (2006).
Silver,R. T.; Bennett,J. M.; Goldman,J. M.; Spivak,J. L.; Tefferi,A.;. "The third international congress on myeloproliferative and myelodysplastic syndromes". Leukemia research (2006).
Greenberg PL, Baer MR, Bennett JM, Bloomfield CD, DeCastro CM, Deeg HJ, Devetten MP, Emanuel PD, Erba HP, Estey E, Foran J, Gore SD, Millenson M, Navarro WH, Nimer SD, ODonnell MR, Saba HI, Spiers K, Stone RM, Tallman MS. "Myelodysplastic Syndromes Clinical Practice Guidelines in Oncology." Journal National Comprehensive Cancer Network (2006).
Cripe Larry D, Rader Kevin S, Tallman Martin S, Gordon Michael S, Paietta Elisabeth, Bennett John M, Neuberg Donna S, Litzow Mark R, OBrien Timothy E, Rowe Jacob M. "Phase II Trial of Subcutaneous Recombinant Human Interleukin 11 with Subcutaneous Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Patients with Acute Myeloid Leukemia (AML) Receiving High-Dose Cytarabine During Induction: ECOG 3997." Leukemia Research (2006).
Bennett JM. "Comment on flow-cytometric analysis of neutrophils." American journal of hematology. 2006; 81(2):155.